OMEROS CORP Research and Development Expense
OMEROS CORP (OMER) reported Research and Development Expense of $13.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-12
- OMEROS CORP research and development expense for the quarter ending 2026-06-30 was $13.80M, a 37.31% decline year-over-year.
- OMEROS CORP research and development expense for the quarter ending 2026-03-31 was $13.36M, a 43.98% decline year-over-year.
- OMEROS CORP research and development expense for the quarter ending 2025-12-31 was $19.45M, a 16.61% decline year-over-year.
- OMEROS CORP research and development expense for the quarter ending 2025-09-30 was $15.99M, a 33.59% decline year-over-year.
- OMEROS CORP research and development expense for fiscal 2025 was $81.30M, a 31.98% decline from fiscal 2024.
- OMEROS CORP research and development expense for fiscal 2024 was $119.52M, a 4.05% increase from fiscal 2023.
- OMEROS CORP research and development expense for fiscal 2023 was $114.87M, a 1.91% increase from fiscal 2022.
- OMEROS CORP research and development expense for fiscal 2022 was $112.72M, a 5.10% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $13.80M 10-Q · filed 2026-08-12 | $27.16M 10-Q · filed 2026-08-12 | $46.60M derived: sum of 3 quarters · filed 2026-08-12 | $62.60M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $13.36M 10-Q · filed 2026-05-13 | $32.80M derived: sum of 2 quarters · filed 2026-05-13 | $48.80M derived: sum of 3 quarters · filed 2026-05-13 | $70.81M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $19.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $35.44M derived: sum of 2 quarters · filed 2026-03-31 | $57.45M derived: sum of 3 quarters · filed 2026-08-12 | $81.30M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $15.99M 10-Q · filed 2025-11-13 | $38.00M derived: sum of 2 quarters · filed 2026-08-12 | $61.85M 10-Q · filed 2025-11-13 | $85.17M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $22.01M 10-Q · filed 2026-08-12 | $45.85M 10-Q · filed 2026-08-12 | $69.17M derived: sum of 3 quarters · filed 2026-08-12 | $93.26M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $23.85M 10-Q · filed 2026-05-13 | $47.17M derived: sum of 2 quarters · filed 2026-05-13 | $71.25M derived: sum of 3 quarters · filed 2026-05-13 | $116.60M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $23.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $47.40M derived: sum of 2 quarters · filed 2026-03-31 | $92.75M derived: sum of 3 quarters · filed 2026-03-31 | $119.52M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $24.08M 10-Q · filed 2025-11-13 | $69.43M derived: sum of 2 quarters · filed 2025-11-13 | $96.20M 10-Q · filed 2025-11-13 | $125.09M derived: sum of 4 quarters · filed 2026-03-31 | ||||
| 2024-06-30 | $45.35M 10-Q · filed 2025-08-14 | $72.12M 10-Q · filed 2025-08-14 | $101.01M derived: sum of 3 quarters · filed 2026-03-31 | $132.74M derived: sum of 4 quarters · filed 2026-03-31 | ||||
| 2024-03-31 | $26.77M 10-Q · filed 2025-05-15 | $55.66M derived: sum of 2 quarters · filed 2026-03-31 | $87.39M derived: sum of 3 quarters · filed 2026-03-31 | $117.03M derived: sum of 4 quarters · filed 2026-03-31 | ||||
| 2023-12-31 | $28.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $60.62M derived: sum of 2 quarters · filed 2026-03-31 | $90.26M derived: sum of 3 quarters · filed 2026-03-31 | $114.87M 10-K · filed 2026-03-31 | ||||
| 2023-09-30 | $31.73M 10-Q · filed 2024-11-13 | $61.37M derived: sum of 2 quarters · filed 2024-11-13 | $85.98M 10-Q · filed 2024-11-13 | $112.53M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-06-30 | $29.64M 10-Q · filed 2024-08-07 | $54.25M 10-Q · filed 2024-08-07 | $80.80M derived: sum of 3 quarters · filed 2025-03-31 | $119.37M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-03-31 | $24.61M 10-Q · filed 2024-05-15 | $51.16M derived: sum of 2 quarters · filed 2025-03-31 | $89.73M derived: sum of 3 quarters · filed 2025-03-31 | $113.24M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2022-12-31 | $26.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $65.12M derived: sum of 2 quarters · filed 2025-03-31 | $88.63M derived: sum of 3 quarters · filed 2025-03-31 | $112.72M 10-K · filed 2025-03-31 | ||||
| 2022-09-30 | $38.57M 10-Q · filed 2023-11-09 | $62.08M derived: sum of 2 quarters · filed 2023-11-09 | $86.17M 10-Q · filed 2023-11-09 | $116.50M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-06-30 | $23.52M 10-Q · filed 2023-08-09 | $47.60M 10-Q · filed 2023-08-09 | $77.93M derived: sum of 3 quarters · filed 2024-04-01 | $103.75M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-03-31 | $24.09M 10-Q · filed 2023-05-09 | $54.41M derived: sum of 2 quarters · filed 2024-04-01 | $80.23M derived: sum of 3 quarters · filed 2024-04-01 | $110.36M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2021-12-31 | $30.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $56.15M derived: sum of 2 quarters · filed 2024-04-01 | $86.27M derived: sum of 3 quarters · filed 2024-04-01 | $118.78M 10-K · filed 2024-04-01 | ||||
| 2021-09-30 | $25.82M 10-Q · filed 2022-11-09 | $27.06M 10-Q · filed 2021-11-09 | $55.94M derived: sum of 2 quarters · filed 2022-11-09 | $88.45M 10-Q · filed 2022-11-09 | $91.36M 10-Q · filed 2021-11-09 | $111.70M derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2021-06-30 | $30.13M 10-Q · filed 2022-08-09 | $30.94M 10-Q · filed 2021-08-09 | $62.63M 10-Q · filed 2022-08-09 | $64.31M 10-Q · filed 2021-08-09 | $85.88M derived: sum of 3 quarters · filed 2023-03-13 | $117.20M derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2021-03-31 | $32.50M 10-Q · filed 2022-05-10 | $33.36M 10-Q · filed 2021-05-10 | $55.76M derived: sum of 2 quarters · filed 2023-03-13 | $87.07M derived: sum of 3 quarters · filed 2023-03-13 | $111.20M derived: sum of 4 quarters · filed 2023-03-13 | |||
| 2020-12-31 | $23.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $54.57M derived: sum of 2 quarters · filed 2023-03-13 | $78.70M derived: sum of 3 quarters · filed 2023-03-13 | $107.61M 10-K · filed 2023-03-13 | $110.82M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $31.32M 10-Q · filed 2021-11-09 | $55.45M derived: sum of 2 quarters · filed 2021-11-09 | $84.36M 10-Q · filed 2021-11-09 | $121.58M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $24.13M 10-Q · filed 2021-08-09 | $53.04M 10-Q · filed 2021-08-09 | $90.26M derived: sum of 3 quarters · filed 2022-03-01 | $114.00M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $28.91M 10-Q · filed 2021-05-10 | $66.13M derived: sum of 2 quarters · filed 2022-03-01 | $89.87M derived: sum of 3 quarters · filed 2022-03-01 | $108.98M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $37.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $60.96M derived: sum of 2 quarters · filed 2022-03-01 | $80.07M derived: sum of 3 quarters · filed 2022-03-01 | $106.32M 10-K · filed 2022-03-01 | $109.70M 10-K · filed 2020-03-02 | |||
| 2019-09-30 | $23.75M 10-Q · filed 2020-11-09 | $42.85M derived: sum of 2 quarters · filed 2020-11-09 | $69.11M 10-Q · filed 2020-11-09 | $94.56M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $19.11M 10-Q · filed 2020-08-10 | $45.36M 10-Q · filed 2020-08-10 | $70.81M derived: sum of 3 quarters · filed 2021-03-01 | $97.67M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $26.25M 10-Q · filed 2020-05-11 | $51.70M derived: sum of 2 quarters · filed 2021-03-01 | $78.56M derived: sum of 3 quarters · filed 2021-03-01 | $97.97M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $25.45M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $52.31M derived: sum of 2 quarters · filed 2021-03-01 | $71.72M derived: sum of 3 quarters · filed 2021-03-01 | $89.86M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $26.86M 10-Q · filed 2019-11-12 | $46.27M derived: sum of 2 quarters · filed 2019-11-12 | $64.41M 10-Q · filed 2019-11-12 | $79.80M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $19.41M 10-Q · filed 2019-08-08 | $37.55M 10-Q · filed 2019-08-08 | $52.94M derived: sum of 3 quarters · filed 2020-03-02 | $67.77M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $18.14M 10-Q · filed 2019-05-09 | $33.53M derived: sum of 2 quarters · filed 2020-03-02 | $48.36M derived: sum of 3 quarters · filed 2020-03-02 | $61.50M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $15.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $30.22M derived: sum of 2 quarters · filed 2020-03-02 | $43.36M derived: sum of 3 quarters · filed 2020-03-02 | $55.60M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $14.84M 10-Q · filed 2018-11-08 | $27.97M derived: sum of 2 quarters · filed 2018-11-08 | $40.21M 10-Q · filed 2018-11-08 | $52.75M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $13.14M 10-Q · filed 2018-08-09 | $25.38M 10-Q · filed 2018-08-09 | $37.92M derived: sum of 3 quarters · filed 2019-03-01 | $50.41M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $12.24M 10-Q · filed 2018-05-10 | $24.78M derived: sum of 2 quarters · filed 2019-03-01 | $37.27M derived: sum of 3 quarters · filed 2019-03-01 | $47.51M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $12.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $25.03M derived: sum of 2 quarters · filed 2019-03-01 | $35.27M derived: sum of 3 quarters · filed 2019-03-01 | $50.70M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $12.49M 10-Q · filed 2017-11-09 | $22.72M derived: sum of 2 quarters · filed 2017-11-09 | $38.16M 10-Q · filed 2017-11-09 | $53.05M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $10.23M 10-Q · filed 2017-08-08 | $25.66M 10-Q · filed 2017-08-08 | $40.56M derived: sum of 3 quarters · filed 2018-03-01 | $53.83M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $15.43M 10-Q · filed 2017-05-10 | $30.33M derived: sum of 2 quarters · filed 2018-03-01 | $43.59M derived: sum of 3 quarters · filed 2018-03-01 | $54.49M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $28.16M derived: sum of 2 quarters · filed 2018-03-01 | $39.06M derived: sum of 3 quarters · filed 2018-03-01 | $48.38M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $13.26M 10-Q · filed 2016-11-09 | $24.16M derived: sum of 2 quarters · filed 2016-11-09 | $33.48M 10-Q · filed 2016-11-09 | $45.23M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $10.90M 10-Q · filed 2016-08-09 | $20.22M 10-Q · filed 2016-08-09 | $31.97M derived: sum of 3 quarters · filed 2017-03-16 | $43.74M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $9.32M 10-Q · filed 2016-05-10 | $21.07M derived: sum of 2 quarters · filed 2017-03-16 | $32.84M derived: sum of 3 quarters · filed 2017-03-16 | $45.25M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $11.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $23.52M derived: sum of 2 quarters · filed 2017-03-16 | $35.93M derived: sum of 3 quarters · filed 2017-03-16 | $47.95M 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $11.77M 10-Q · filed 2015-11-09 | $24.18M derived: sum of 2 quarters · filed 2015-11-09 | $36.20M 10-Q · filed 2015-11-09 | $46.38M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $12.41M 10-Q · filed 2015-08-10 | $24.42M 10-Q · filed 2015-08-10 | $34.61M derived: sum of 3 quarters · filed 2016-03-15 | $44.03M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $12.02M 10-Q · filed 2015-05-11 | $22.20M derived: sum of 2 quarters · filed 2016-03-15 | $31.62M derived: sum of 3 quarters · filed 2016-03-15 | $41.19M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $10.19M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $19.61M derived: sum of 2 quarters · filed 2016-03-15 | $29.17M derived: sum of 3 quarters · filed 2016-03-15 | $36.30M 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | $9.42M 10-Q · filed 2014-11-10 | $18.98M derived: sum of 2 quarters · filed 2014-11-10 | $26.11M 10-Q · filed 2014-11-10 | $35.47M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-06-30 | $9.56M 10-Q · filed 2014-08-11 | $16.69M 10-Q · filed 2014-08-11 | $26.05M derived: sum of 3 quarters · filed 2015-03-16 | $33.81M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-03-31 | $7.13M 10-Q · filed 2014-05-12 | $16.48M derived: sum of 2 quarters · filed 2015-03-16 | $24.25M derived: sum of 3 quarters · filed 2015-03-16 | $31.80M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2012-12-31 | $9.35M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $17.12M derived: sum of 2 quarters · filed 2015-03-16 | $24.68M derived: sum of 3 quarters · filed 2015-03-16 | $31.92M 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | $7.76M 10-Q · filed 2013-11-07 | $15.32M derived: sum of 2 quarters · filed 2013-11-07 | $22.57M 10-Q · filed 2013-11-07 | $31.46M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $7.56M 10-Q · filed 2013-08-09 | $14.80M 10-Q · filed 2013-08-09 | $23.70M derived: sum of 3 quarters · filed 2014-03-13 | $29.02M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $7.25M 10-Q · filed 2013-05-09 | $16.14M derived: sum of 2 quarters · filed 2014-03-13 | $21.46M derived: sum of 3 quarters · filed 2014-03-13 | $25.54M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $8.89M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $14.22M derived: sum of 2 quarters · filed 2014-03-13 | $18.29M derived: sum of 3 quarters · filed 2014-03-13 | $23.72M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $5.32M 10-Q · filed 2012-11-09 | $9.40M derived: sum of 2 quarters · filed 2012-11-09 | $14.82M 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | $4.08M 10-Q · filed 2012-08-07 | $9.50M 10-Q · filed 2012-08-07 | ||||||
| 2011-03-31 | $5.42M 10-Q · filed 2012-05-10 | |||||||
| 2010-12-31 | $23.46M 10-K · filed 2013-03-18 | |||||||
| 2009-12-31 | $16.93M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |